Symphony Ltd — earnings calls
2 quarters summarised from transcripts filed with the exchange, every statement cited. Newest first.
Symphony reported consolidated Q1 FY27 revenue of ₹378 crore, up 8% YoY, with EBITDA at ₹48 crore and PAT at ₹40 crore, while management noted these figures included one-time items that, if excluded, would show adjusted EBITDA of ₹53 crore and adjusted PAT of ₹43 crore. Domestic standalone revenue grew 15% YoY to ₹241 crore, with modern trade channels growing over 100% and no inventory overhang remaining as of quarter end. Bonaire USA and GSK China posted strong growth of 35% and 43% respectively, while IMPCO Mexico and CTPL Australia remained weak due to mild summers and reduced demand.
Symphony reported consolidated FY26 revenue of ₹1,131 crores, down 28% year-on-year, with PAT turning negative at ₹141 crores after exceptional impairment charges related to the Australia business. Management fully impaired its equity investment in Climate Technologies Australia worth ₹348 crores and ring-fenced the U.S. business as a direct subsidiary of Symphony India. Standalone Q4 FY26 revenue fell to ₹199 crores from ₹368 crores, with management citing channel inventory overhang and a weak summer season in North and East India.